Identification of candidate miRNA biomarkers from miRNA regulatory network with application to prostate cancer

Journal of Translational Medicine

Volumn 12, Issue 1, 2014, Pages

  Zhang, Wenyu ^a   Zang, Jin ^b   Jing, Xinhua ^a   Sun, Zhandong ^a   Yan, Wenying ^a   Yang, Dongrong ^c   Guo, Feng ^b   Shen, Bairong ^a  

^a SOOCHOW UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Gene expression; miRNA biomarker; miRNA regulatory network; Prostate cancer

Indexed keywords

MESSENGER RNA; MICRORNA; TUMOR MARKER;

ARTICLE; BIOINFORMATICS; CANCER GROWTH; CLINICAL FEATURE; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE INTERACTION; GENE REGULATORY NETWORK; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; IN VITRO STUDY; MALE; POLYMERASE CHAIN REACTION; PREDICTION; PROSTATE CANCER;

DATABASES, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE ONTOLOGY; GENE REGULATORY NETWORKS; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MICRORNAS; MOLECULAR SEQUENCE ANNOTATION; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 84897486492     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-12-66     Document Type: Article

References (58)

1. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297. 10.1016/S0092-8674(04)00045-5, 14744438.
2. Dar AA, Majid S, de Semir D, Nosrati M, Bezrookove V, Kashani-Sabet M. miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein. J Biol Chem 2011, 286:16606-16614. 10.1074/jbc.M111.227611, 3089503, 21454583.
3. Kulozik AE. Stay tuned: miRNA expression and nonsense-mediated decay in brain development. Mol Cell 2011, 42:407-408. 10.1016/j.molcel.2011.05.002, 21596305.
4. He JF, Luo YM, Wan XH, Jiang D. Biogenesis of MiRNA-195 and its role in biogenesis, the cell cycle, and apoptosis. J Biochem Mol Toxicol 2011, 25:404-408. 10.1002/jbt.20396, 22190509.
5. Humeau M, Torrisani J, Cordelier P. miRNA in clinical practice: pancreatic cancer. Clin Biochem 2013, 46:933-936. 10.1016/j.clinbiochem.2013.03.019, 23570860.
6. Kojima S, Naya Y, Ichikawa T, Seki N. MiRNA profiling in prostate cancer. Nihon Rinsho 2011, 69(Suppl 5):92-95.
7. Pignot G, Cizeron-Clairac G, Vacher S, Susini A, Tozlu S, Vieillefond A, Zerbib M, Lidereau R, Debre B, Amsellem-Ouazana D, Bieche I. MicroRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer. Int J Cancer 2013, 132:2479-2491. 10.1002/ijc.27949, 23169479.
8. Lerebours F, Cizeron-Clairac G, Susini A, Vacher S, Mouret-Fourme E, Belichard C, Brain E, Alberini JL, Spyratos F, Lidereau R, Bieche I. miRNA expression profiling of inflammatory breast cancer identifies a 5-miRNA signature predictive of breast tumor aggressiveness. Int J Cancer 2013, 133:1614-1623. 10.1002/ijc.28171, 23526361.
9. Chen J, Zhang D, Zhang W, Tang Y, Yan W, Guo L, Shen B. Clear cell renal cell carcinoma associated microRNA expression signatures identified by an integrated bioinformatics analysis. J Transl Med 2013, 11:169. 10.1186/1479-5876-11-169, 3740788, 23841900.
10. Tang Y, Yan W, Chen J, Luo C, Kaipia A, Shen B. Identification of novel microRNA regulatory pathways associated with heterogeneous prostate cancer. BMC Syst Biol 2013, 7(3):S6.
11. Madden SF, Carpenter SB, Jeffery IB, Bjorkbacka H, Fitzgerald KA, O'Neill LA, Higgins DG. Detecting microRNA activity from gene expression data. BMC Bioinforma 2010, 11:257.
12. Xu J, Li CX, Lv JY, Li YS, Xiao Y, Shao TT, Huo X, Li X, Zou Y, Han QL, Li X, Wang LH, Ren H. Prioritizing candidate disease miRNAs by topological features in the miRNA target-dysregulated network: case study of prostate cancer. Mol Cancer Ther 2011, 10:1857-1866. 10.1158/1535-7163.MCT-11-0055, 21768329.
13. Yoon S, De Micheli G. Prediction of regulatory modules comprising microRNAs and target genes. Bioinformatics 2005, 21(Suppl 2):ii93-ii100.
14. Zhang W, Edwards A, Fan W, Flemington EK, Zhang K. miRNA-mRNA correlation-network modules in human prostate cancer and the differences between primary and metastatic tumor subtypes. PLoS One 2012, 7:e40130. 10.1371/journal.pone.0040130, 3387006, 22768240.
15. Kim SJ, Ha JW, Zhang BT. Constructing higher-order miRNA-mRNA interaction networks in prostate cancer via hypergraph-based learning. BMC Syst Biol 2013, 7:47. 10.1186/1752-0509-7-47, 3733828, 23782521.
16. Bonnet E, Michoel T, Van de Peer Y. Prediction of a gene regulatory network linked to prostate cancer from gene expression, microRNA and clinical data. Bioinformatics 2010, 26:i638-i644. 10.1093/bioinformatics/btq395, 2935430, 20823333.
17. Zhang S, Li Q, Liu J, Zhou XJ. A novel computational framework for simultaneous integration of multiple types of genomic data to identify microRNA-gene regulatory modules. Bioinformatics 2011, 27:i401-i409. 10.1093/bioinformatics/btr206, 3117336, 21685098.
18. Bandyopadhyay S, Mitra R, Maulik U, Zhang MQ. Development of the human cancer microRNA network. Silence 2010, 1:6. 10.1186/1758-907X-1-6, 2835996, 20226080.
19. He HC, Zhu JG, Chen XB, Chen SM, Han ZD, Dai QS, Ling XH, Fu X, Lin ZY, Deng YH, Qin GQ, Cai C, Chen JH, Zhong WD. MicroRNA-23b downregulates peroxiredoxin III in human prostate cancer. FEBS Lett 2012, 586:2451-2458. 10.1016/j.febslet.2012.06.003, 22710126.
20. Chen JH, He HC, Jiang FN, Militar J, Ran PY, Qin GQ, Cai C, Chen XB, Zhao J, Mo ZY, Chen YR, Zhu JG, Liu X, Zhong WD. Analysis of the specific pathways and networks of prostate cancer for gene expression profiles in the Chinese population. Med Oncol 2012, 29:1972-1984. 10.1007/s12032-011-0088-5, 22038724.
21. Xiao F, Zuo Z, Cai G, Kang S, Gao X, Li T. miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res 2009, 37:D105-D110. 10.1093/nar/gkn851, 2686554, 18996891.
22. Sethupathy P, Corda B, Hatzigeorgiou AG. TarBase: A comprehensive database of experimentally supported animal microRNA targets. RNA 2006, 12:192-197. 1370898, 16373484.
23. Jiang Q, Wang Y, Hao Y, Juan L, Teng M, Zhang X, Li M, Wang G, Liu Y. miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Res 2009, 37:D98-D104. 10.1093/nar/gkn714, 2686559, 18927107.
24. Hsu SD, Lin FM, Wu WY, Liang C, Huang WC, Chan WL, Tsai WT, Chen GZ, Lee CJ, Chiu CM, Chien CH, Wu MC, Huang CY, Tsou AP, Huang HD. miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res 2011, 39:D163-D169. 10.1093/nar/gkq1107, 3013699, 21071411.
25. Gennarino VA, Sardiello M, Avellino R, Meola N, Maselli V, Anand S, Cutillo L, Ballabio A, Banfi S. MicroRNA target prediction by expression analysis of host genes. Genome Res 2009, 19:481-490. 2661810, 19088304.
26. Gamazon ER, Im HK, Duan S, Lussier YA, Cox NJ, Dolan ME, Zhang W. Exprtarget: an integrative approach to predicting human microRNA targets. PLoS One 2010, 5:e13534. 10.1371/journal.pone.0013534, 2958831, 20975837.
27. Yang JH, Li JH, Shao P, Zhou H, Chen YQ, Qu LH. starBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data. Nucleic Acids Res 2011, 39:D202-D209. 10.1093/nar/gkq1056, 3013664, 21037263.
28. Chen J, Qian F, Yan W, Shen B. Translational biomedical informatics in the cloud: present and future. Biomed Res Int 2013, 2013:658925. 3613081, 23586054.
29. Chen J, Wang Y, Shen B, Zhang D. Molecular signature of cancer at gene level or pathway level? Case studies of colorectal cancer and prostate cancer microarray data. Comput Math Methods Med 2013, 2013:909525. 3562646, 23401724.
30. Chen J, Zhang D, Yan W, Yang D, Shen B. Translational bioinformatics for diagnostic and prognostic prediction of prostate cancer in the next-generation sequencing era. Biomed Res Int 2013, 2013:901578. 3727129, 23957008.
31. Jiang J, Cui W, Vongsangnak W, Hu G, Shen B. Post genome-wide association studies functional characterization of prostate cancer risk loci. BMC Genomics 2013, 14(8):S9.
32. Roh YH, Noh JH, Kim W, Oh JH, Gong HS, Baek GH. Cross-cultural adaptation and validation of the Korean version of the Oxford shoulder score. Arch Orthop Trauma Surg 2012, 132:93-99. 10.1007/s00402-011-1393-3, 21959695.
33. Wei K, Chen J, Chen Y, Wu L, Xie D. Multiple-strategy analyses of ZmWRKY subgroups and functional exploration of ZmWRKY genes in pathogen responses. Mol Biosyst 2012, 8:1940-1949. 10.1039/c2mb05483c, 22569521.
34. Kurahashi I, Fujita Y, Arao T, Kurata T, Koh Y, Sakai K, Matsumoto K, Tanioka M, Takeda K, Takiguchi Y, Yamamoto N, Tsuya A, Matsubara N, Mukai H, Minami H, Chayahara N, Yamanaka Y, Miwa K, Takahashi S, Nakagawa K, Nishio K. A microarray-based gene expression analysis to identify diagnostic biomarkers for unknown primary cancer. PLoS One 2013, 8:e63249. 10.1371/journal.pone.0063249, 3650062, 23671674.
35. Stoss O, Werther M, Zielinski D, Middel P, Jost N, Ruschoff J, Henkel T, Albers P. Transcriptional profiling of transurethral resection samples provides insight into molecular mechanisms of hormone refractory prostate cancer. Prostate Cancer Prostatic Dis 2008, 11:166-172. 10.1038/sj.pcan.4501001, 17646850.
36. Tamura K, Furihata M, Tsunoda T, Ashida S, Takata R, Obara W, Yoshioka H, Daigo Y, Nasu Y, Kumon H, Konaka H, Namiki M, Tozawa K, Kohri K, Tanji N, Yokoyama M, Shimazui T, Akaza H, Mizutani Y, Miki T, Fujioka T, Shuin T, Nakamura Y, Nakagawa H. Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profiles. Cancer Res 2007, 67:5117-5125. 10.1158/0008-5472.CAN-06-4040, 17545589.
37. Hsu PW, Huang HD, Hsu SD, Lin LZ, Tsou AP, Tseng CP, Stadler PF, Washietl S, Hofacker IL. miRNAMap: genomic maps of microRNA genes and their target genes in mammalian genomes. Nucleic Acids Res 2006, 34:D135-D139. 10.1093/nar/gkj135, 1347497, 16381831.
38. da Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4:44-57.
39. Ogata H, Goto S, Sato K, Fujibuchi W, Bono H, Kanehisa M. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res 1999, 27:29-34. 10.1093/nar/27.1.29, 148090, 9847135.
40. Liu G, Ding M, Chen J, Huang J, Wang H, Jing Q, Shen B. Computational analysis of microRNA function in heart development. Acta Biochim Biophys Sin (Shanghai) 2010, 42:662-670. 10.1093/abbs/gmq072, 20716610.
41. Jayaswal V, Lutherborrow M, Ma DD, Yang YH. Identification of microRNA-mRNA modules using microarray data. BMC Genomics 2011, 12:138. 10.1186/1471-2164-12-138, 3065435, 21375780.
42. Tran DH, Satou K, Ho TB. Finding microRNA regulatory modules in human genome using rule induction. BMC Bioinforma 2008, 9(12):S5.
43. Delprato A. Topological and functional properties of the small GTPases protein interaction network. PLoS One 2012, 7:e44882. 10.1371/journal.pone.0044882, 3441499, 23028658.
44. Yang Z, Ren F, Liu C, He S, Sun G, Gao Q, Yao L, Zhang Y, Miao R, Cao Y, Zhao Y, Zhong Y, Zhao H. dbDEMC: a database of differentially expressed miRNAs in human cancers. BMC Genomics 2010, 11(4):S5.
45. Roa W, Brunet B, Guo L, Amanie J, Fairchild A, Gabos Z, Nijjar T, Scrimger R, Yee D, Xing J. Identification of a new microRNA expression profile as a potential cancer screening tool. Clin Invest Med 2010, 33:E124.
46. Du L, Schageman JJ, Subauste MC, Saber B, Hammond SM, Prudkin L, Wistuba II, Ji L, Roth JA, Minna JD, Pertsemlidis A. miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1. Mol Cancer Res 2009, 7:1234-1243. 10.1158/1541-7786.MCR-08-0507, 2741087, 19671678.
47. Luo J, Liu X. Polo-like kinase 1, on the rise from cell cycle regulation to prostate cancer development. Protein Cell 2012, 3:182-197. 10.1007/s13238-012-2020-y, 22447658.
48. Gurumurthy S, Vasudevan KM, Rangnekar VM. Regulation of apoptosis in prostate cancer. Cancer Metastasis Rev 2001, 20:225-243. 10.1023/A:1015583310759, 12085964.
49. Wang Q, Symes AJ, Kane CA, Freeman A, Nariculam J, Munson P, Thrasivoulou C, Masters JR, Ahmed A. A novel role for Wnt/Ca2+ signaling in actin cytoskeleton remodeling and cell motility in prostate cancer. PLoS One 2010, 5:e10456. 10.1371/journal.pone.0010456, 2864254, 20454608.
50. Wang Y, Chen J, Li Q, Wang H, Liu G, Jing Q, Shen B. Identifying novel prostate cancer associated pathways based on integrative microarray data analysis. Comput Biol Chem 2011, 35:151-158. 10.1016/j.compbiolchem.2011.04.003, 21704261.
51. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009, 19:92-105. 2612969, 18955434.
52. Rosenbaum E, Begum S, Brait M, Zahurak M, Maldonado L, Mangold LA, Eisenberger MA, Epstein JI, Partin AW, Sidransky D, Hoque MO. AIM1 promoter hypermethylation as a predictor of decreased risk of recurrence following radical prostatectomy. Prostate 2012, 72:1133-1139. 10.1002/pros.22461, 3360823, 22127895.
53. Tourkova IL, Yurkovetsky ZR, Gambotto A, Makarenkova VP, Perez L, Balkir L, Robbins PD, Shurin MR, Shurin GV. Increased function and survival of IL-15-transduced human dendritic cells are mediated by up-regulation of IL-15Ralpha and Bcl-2. J Leukoc Biol 2002, 72:1037-1045.
54. Gromova I, Gromov P, Kroman N, Wielenga VT, Simon R, Sauter G, Moreira JM. Immunoexpression analysis and prognostic value of BLCAP in breast cancer. PLoS One 2012, 7:e45967. 10.1371/journal.pone.0045967, 3458104, 23049907.
55. Bommer GT, Jager C, Durr EM, Baehs S, Eichhorst ST, Brabletz T, Hu G, Frohlich T, Arnold G, Kress DC, Goke B, Fearon ER, Kolligs FT. DRO1, a gene down-regulated by oncogenes, mediates growth inhibition in colon and pancreatic cancer cells. J Biol Chem 2005, 280:7962-7975. 10.1074/jbc.M412593200, 15563452.
56. Choo A, Palladinetti P, Holmes T, Basu S, Shen S, Lock RB, O'Brien TA, Symonds G, Dolnikov A. siRNA targeting the IRF2 transcription factor inhibits leukaemic cell growth. Int J Oncol 2008, 33:175-183.
57. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 2007, 27:91-105. 10.1016/j.molcel.2007.06.017, 3800283, 17612493.
58. Kruger J, Rehmsmeier M. RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res 2006, 34:W451-W454. 10.1093/nar/gkl243, 1538877, 16845047.